Belluscura PLC Total Voting Rights
31 Julio 2024 - 7:11AM
RNS Regulatory News
RNS Number : 6290Y
Belluscura PLC
31 July 2024
31 July 2024
Belluscura plc
("Belluscura" or the "Company")
Total Voting Rights
Belluscura plc (AIM: BELL), a
leading medical device developer focused on lightweight and
portable oxygen enrichment technology, announces
that the total number of Ordinary Shares in the capital of the
Company in issue is 168,408,232 with each Ordinary Share
carrying the right to one vote. There are no Ordinary Shares
held in treasury and therefore the total number of voting rights in
the Company is 168,408,232. The above figure
may be used by Shareholders in the Company as the denominator for
the calculations by which they will determine if they are required
to notify their interest in, or a change to their interest in, the
share capital of the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Enquiries:
For further
information, please contact:
|
Belluscura
plc
|
www.belluscura.com
|
|
Robert Rauker, Chief Executive
Officer
|
via MHP
|
|
Simon Neicheril, Chief Financial
Officer
|
|
|
|
|
|
SPARK Advisory
Partners Limited
(NOMAD)
|
Tel: +44 (0)20 3368 3550
|
|
Neil Baldwin / Jade Bayat
|
|
|
|
|
|
Dowgate Capital Limited
(Broker)
|
Tel: +44 (0)20 3903 7715
|
|
James Serjeant / Russell Cook /
Nicholas Chambers
|
|
|
|
|
|
MHP
Communications
(Financial PR and Investor Relations)
|
Tel: +44 (0)20 3128 8100 / +44 7884
494112
Email: belluscura@mhpgroup.com
|
|
Katie Hunt / Matthew Taylor
|
|
|
|
|
About Belluscura plc
( www.belluscura.com )
Belluscura is a UK medical device
company focused on developing high performing, lightweight and
portable oxygen enrichment technology used in a broad range of
industries and therapies. Our innovative oxygen technologies are
designed with a global purpose: to create improved health, mobility
and economic outcomes for patients, healthcare providers and
insurance organisations.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVRSDSFEFELSEFW
Belluscura (LSE:BELL)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Belluscura (LSE:BELL)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
